A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall
Príomhchruthaitheoirí: | , , , , , , , , , , , , , |
---|---|
Formáid: | Conference item |
Teanga: | English |
Foilsithe / Cruthaithe: |
Oxford University Press
2021
|